Effects of environmental Bisphenol A exposures on germ cell development and Leydig cell function in the human fetal testis by Eladak, Soria et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Effects of environmental Bisphenol A exposures on germ cell
development and Leydig cell function in the human fetal testis
Citation for published version:
Eladak, S, Moison, D, Guerquin, M-J, Matilionyte, G, Kilcoyne, K, N'Tumba-Byn, T, Messiaen, S,
Deceuninck, Y, Pozzi-Gaudin, S, Benachi, A, Livera, G, Antignac, J-P, Mitchell, R, Rouiller-Fabre, V &
Habert, R 2018, 'Effects of environmental Bisphenol A exposures on germ cell development and Leydig cell
function in the human fetal testis' PLoS One. DOI: 10.1371/journal.pone.0191934
Digital Object Identifier (DOI):
10.1371/journal.pone.0191934
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
PLoS One
Publisher Rights Statement:
 This is an open access article distributed under the terms of the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source
are credited.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
RESEARCH ARTICLE
Effects of environmental Bisphenol A
exposures on germ cell development and
Leydig cell function in the human fetal testis
Soria Eladak1,2,3☯, Delphine Moison1,2,3☯, Marie-Justine Guerquin1,2,3,
Gabriele Matilionyte4, Karen Kilcoyne4, Thierry N’Tumba-Byn1,2,3, Se´bastien Messiaen1,2,3,
Yoann Deceuninck5, Ste´phanie Pozzi-Gaudin6, Alexandra Benachi6, Gabriel Livera1,2,3,
Jean-Philippe Antignac5, Rod Mitchell4‡, Virginie Rouiller-Fabre1,2,3‡, Rene´ Habert1,2,3‡*
1 Univ. Paris Diderot, Sorbonne Paris Cite´, Laboratory of Development of the Gonads, Unit of Genetic
Stability, Stem Cells and Radiation, Fontenay-aux-Roses, France, 2 CEA, DSV, iRCM, SCSR, LDG,
Fontenay-aux-Roses, France, 3 INSERM, Unite´ 967, Fontenay aux Roses, France, 4 MRC Centre for
Reproductive Health, The University of Edinburgh, The Queen’s Medical Research Institute, Edinburgh,
Scotland, United Kingdom, 5 Laboratoire d’Etude des Re´sidus et Contaminants dans les Aliments
(LABERCA), Ecole Nationale Ve´te´rinaire Agroalimentaire et de l’Alimentation Nantes Atlantique (ONIRIS),
Nantes, France, 6 Service de Gyne´cologie-Obste´trique et Me´decine de la Reproduction, Hoˆpital A. Be´clère,
Universite´ Paris Sud, Clamart, France
☯ These authors contributed equally to this work.
‡ These authors contributed equally to this work
* rene.habert@cea.fr
Abstract
Background
Using an organotypic culture system termed human Fetal Testis Assay (hFeTA) we previ-
ously showed that 0.01 μM BPA decreases basal, but not LH-stimulated, testosterone
secreted by the first trimester human fetal testis. The present study was conducted to deter-
mine the potential for a long-term antiandrogenic effect of BPA using a xenograft model, and
also to study the effect of BPA on germ cell development using both the hFETA and xeno-
graft models.
Methods
Using the hFeTA system, first trimester testes were cultured for 3 days with 0.01 to 10 μM
BPA. For xenografts, adult castrate male nude mice were injected with hCG and grafted
with first trimester testes. Host mice received 10 μM BPA (~ 500 μg/kg/day) in their drinking
water for 5 weeks. Plasma levels of total and unconjugated BPA were 0.10 μM and
0.038 μM respectively. Mice grafted with second trimester testes received 0.5 and 50 μg/kg/
day BPA by oral gavage for 5 weeks.
Results
With first trimester human testes, using the hFeTA model, 10 μM BPA increased germ cell
apoptosis. In xenografts, germ cell density was also reduced by BPA exposure. Importantly,
BPA exposure significantly decreased the percentage of germ cells expressing the
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pluripotency marker AP-2γ, whilst the percentage of those expressing the pre-spermatogo-
nial marker MAGE-A4 significantly increased. BPA exposure did not affect hCG-stimulated
androgen production in first and second trimester xenografts as evaluated by both plasma
testosterone level and seminal vesicle weight in host mice.
Conclusions
Exposure to BPA at environmentally relevant concentrations impairs germ cell development
in first trimester human fetal testis, whilst gonadotrophin-stimulated testosterone production
was unaffected in both first and second trimester testis. Studies using first trimester human
fetal testis demonstrate the complementarity of the FeTA and xenograft models for deter-
mining the respective short-term and long term effects of environmental exposures.
Introduction
Over recent decades, the incidence of male reproductive disorders has been steadily increasing
[1–4]. These disorders such as cryptorchidism, hypospadias, low sperm count and quality, and
testicular cancer are hypothesized to arise from abnormal development of the fetal testis.
These associated disorders have been collectively described as a testicular dysgenesis syndrome
(TDS) [5–8].
In 1993, Sharpe and Skakkebaek hypothesized that endocrine disruptors (EDs), particularly
EDs with an estrogenic effect, could be an explanation for the increase in male reproductive
disorders [9] initiating a large number of studies in reproductive toxicology [4,10,11]. Among
such EDs, bisphenol A (BPA; 4,4’-dihydroxy-2,2-diphenylpropane) has been the focus of con-
siderable research [12–15].
BPA is one of the most frequently produced synthetic chemicals worldwide, with approxi-
mately 70% used to produce polycarbonate plastics for a variety of products, including house-
wares and appliances, opticals, construction materials and medical, packaging. A further 20%
of BPA is used as an essential component of epoxy resins that are mainly used to coat the inner
surface of metallic food and beverage cans. Finally, BPA is used as antioxidant or inhibitor of
polymerization in some plasticizers, polyvinyl chloride, and thermal cash register paper.
Many studies have shown that BPA exposure of rodents during intrauterine life can induce
a range of adverse effects in adult testes. It has been shown that in utero or perinatal BPA expo-
sure induces a decrease in sperm quality and production and testosterone secretion in adults
[14,16–21]. These results suggest that BPA potentially disturbs fetal testis development and
future function.
However, there is limited data and conflicting results concerning the direct immediate
effect of in vivo BPA exposure on fetal testis development and function. In pregnant rats,
exposure to high doses of BPA (876 μM i.e. calculated to be approximately 20,000 μg/kg/day,
based on an adult rat weight of 300 g and a fluid intake of about 30 mL/day) in drinking water
reduced plasma testosterone in the offspring at birth [22]. Gavage of pregnant rats with 1–200
mg/kg/day BPA increased the mRNA level but not the protein levels of Raf1 in the Leydig cells
at postnatal day 3 [23]. Administration of 250 μg/kg/day BPA reduced the anogenital distance
in male rat pups, which suggests a reduction in fetal androgen exposure, whereas lower BPA
doses did not have any effect [24]. On the contrary, three other studies investigating potential
effects of BPA exposure, found no difference in AGD between BPA and vehicle exposed pups
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following gestational gavage with doses equal or higher than 1 mg/kg/day and reaching 200 to
50000 mg/kg/day [25–27].
Furthermore, recent ex vivo analyses have demonstrated the complexity of the potential
effect of BPA on Leydig cell function and development. Using an organotypic culture system
termed “Fetal Testis Assay” (FeTA) developed for rat fetal testis in 1990’s [28] and extended
for mouse and human fetal testes thereafter [29,30], we demonstrated that BPA concentrations
as low as 0.01 μM (i.e. 2.28 μg/L) reduced basal testosterone secretion and Insl-3 expression by
the human fetal testis, but not by mouse and rat fetal testes for which concentrations equal or
higher to 1 μM BPA were required in order to induce similar effects [31]. This was confirmed
for human fetal testes subsequently by another laboratory using the same FeTA approach [32].
In the continuous presence of LH or hCG, 1 or 10 μM BPA was necessary to reduce testoster-
one secretion in human, mouse and rat [15,32].
To date, no study has investigated the effect of BPA on male germ cell (GC) development
during fetal life in either rodent or human models. Fetal primordial GC migrate into the
embryonic genital ridge. By 7 weeks of gestation in human they are enclosed in the seminifer-
ous cords at which point they are termed gonocytes [33–36]. Gonocytes express the pluripo-
tency markers such as Activating Enhancer Binding Protein 2 Gamma (AP-2y), a transcription
factor associated with an undifferentiated state and encoded by the TFAP2C gene. As GC differ-
entiate from gonocytes to pre-spermatogonia the expression of AP-2y is reduced and the cells
begin to express Melanoma Associated Antigen A4 (MAGE-A4) a differentiation marker also
expressed in adult spermatogonia [37–42]. In rodents, this transition from gonocyte to pre-
spermatogonia occurs synchronously during late gestation, whereas in humans this transition
occurs asynchronously over the remainder of fetal and into early postnatal life [37,38,40,42–
44]. During the first trimester of gestation, we have previously shown that the rate of GC prolif-
eration is ~25–30%, and ~1–3% of GC are apoptotic [36]. In the second trimester ~20–25% of
gonocytes are proliferative, compared with only ~3% of pre-spermatogonia at this stage [41].
The present study was designed to investigate the effects of BPA on both endocrine func-
tion and GC development in the human fetal testis. We combined two experimental models:
we used the ‘short term’ organotypic culture system (FeTA) and the ‘long term’ xenograft sys-
tem [41,45,46], both of which have been validated for assessment of effects of exposures to
chemicals on human fetal testis development.
The specific aims were 1) to investigate the potential for an antiandrogenic effects of BPA
in human fetal testes from the first and the second trimesters using the xenograft system 2) to
study the effect of BPA on GC development in first trimester testes using both FeTA and xeno-
graft systems, 3) to compare the results of the two experimental models using first trimester
testis tissue.
Materials and methods
First trimester human Fetal Testis Assay (hFeTA) and xenograft studies
Collection of human fetal testis. Human fetal testes (5–12 Gestational Weeks; GW) were
obtained from pregnant women referred to the Department of Gynecology and Obstetrics at
the Antoine Be´clère hospital (Clamart, France) for legally induced abortions in the first trimes-
ter of pregnancy as previously described [30]. All women provided written informed consent
for scientific use of the fetal tissues. None of the abortions were due to fetal abnormality. The
fetal age was determined by measuring the length of limbs and feet [47]. Gonads within the
abortive material were retrieved in 50% of cases. Testes were identified based on their size and
their morphology. The project was approved by the local Medical Ethics Committee and by
the French Biomedicine Agency (reference number PFS 12–002).
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Human Fetal Testis Assay (hFeTA). Human Fetal Testis Assay (hFeTA) is the organoty-
pic culture system developed in our laboratory and largely described previously [28–30,48,49].
Briefly, human testes were cut into small pieces (12 to 30 pieces depending on the age of the
fetus) and 3–4 pieces were randomly placed on Millicell-CM Biopore membranes (pore size
0.4 μm, Millipore, Billerica, MA) floating on 320 μL culture medium in tissue culture dishes.
Cultures were performed at 37˚C in a humidified atmosphere containing 95% air/ 5% CO2.
The culture medium was phenol-red free Dulbecco modified Eagle medium/Ham F12 (1:1;
Gibco, Grand Island, NY), supplemented with 80 μg/mL gentamicin (Sigma, St. Louis, MO).
BPA was purchased from Sigma (CAS no. 80-09-1; Sigma, St. Louis, MO) and diluted in
ethanol.
After 24 hours in control medium, explants were cultured with 100 ng/mL LH from human
pituitary ( 5,000 IU/mg; Sigma) in the presence of ethanol vehicle (control explants) or BPA
at concentrations ranging from 0.01 to 10 μM for three subsequent days. Control and treated
explants were from the same testis. The whole culture medium was changed every 24h. At the
end of the culture, explants were fixed in Bouin’s and formaldehyde for analysis of cell apopto-
sis and proliferation of germ cells as previously described [30,48].
Host mice for xenografting. Nude mice (NMRI-Foxnlnu/foxnlnu) from Janvier (Saint
Berthevin, France) were received at 4 weeks-old and housed in our animal facility under con-
trolled photoperiod conditions (lights on 08:00 am to 08:00 pm). They were supplied with
estrogen-free commercial food and tap water ad libitum. Mice received water via glass water
bottles. The animal facility is licensed by the French Ministry of Agriculture (agreement n˚
B92-032-02). All efforts were made to avoid or minimize animal suffering.
Xenografting procedure. Pieces of human fetal testis were xenografted into the muscle of
the back as previously described for ovarian xenografts [50]. Briefly, both human fetal testes
from 9 fetuses (9.1 to 11.3 GW) were cut into pieces (~1 mm3 approx.). Male Nude mice (aged
5–8 weeks) were anesthetized by isoflurane inhalation. All pieces from one testis were grafted
in one mouse which was then exposed to BPA whilst all the pieces from the other testis of the
same human fetus were grafted into another mouse which will serve as a control. The testicular
pieces were inserted in the left back muscle of the host mice. Mice were then immediately cas-
trated and injected subcutaneously with 20 IU hCG (Human Chorionic Gonadotrophin, MSD
France). Mice received analgesia (Carprofen, 25μg/mL, Santa Cruz, sc 205621) in the drinking
water for one recovery week post-surgery.
Six weeks post-xenografting, the xenografted testes were visible as subcutaneous swellings
of the host mouse indicating growth of the xenografts in this in vivo model (Fig 1A). Xeno-
grafts were approximately five times larger than they were when grafted. After euthanasia the
xenografts were visible in the back muscle by their white color and their large size in both con-
trol and BPA-treated host mice, (Fig 1B).
Histological sections of both control and BPA-treated xenografted testes exhibited a well-
maintained architecture with Sertoli cells surrounding the germ cells in the seminiferous cords
and the Leydig cells in the interstitial compartment (Fig 1C and 1D). Furthermore, in histolog-
ical sections blood vessels were present inside the xenografted tissues. There was no evidence
of necrosis, demonstrating that the size of xenografted pieces of testis was suitable for support-
ing good vascularization of tissues and that the xenografting procedure preserved normal his-
tological appearance of the testis (Fig 1C and 1D).
Treatment of host mice. All the mice were injected subcutaneously every 72h with 20 IU
hCG from the day of surgery until euthanasia. After one recovery week, host mice received
drinking water containing 0.1% ethanol (control mice) or BPA diluted in 0.1% ethanol to
obtain 10 μM BPA as the final concentration (BPA-treated mice) for the five subsequent
weeks. During the treatment period, mice were weighed every week. BPA treatment did not
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affect the body weight of the mice compared to controls. As one adult mouse weighs ~30 g and
drinks ~7 mL of water per day the evaluated daily intake of BPA by treated mice is ~500 μg/kg
of body weight/day. For comparison, the US Food and Drug Administration (FDA) and the
European Food Safety Authority (EFSA) have determined the NOAEL for BPA to be equal to
5,000 and 8,960 μg/kg of body weight/day in rodents respectively.
Sampling in xenograft model. At the end of the grafting period, host mice were anesthe-
tized by isoflurane inhalation and blood was extracted by cardiac puncture for testosterone
and BPA measurements. Mice were killed by cervical dislocation and seminal vesicles were
removed and weighed. Xenografts were retrieved and fixed in Bouin’s fluid overnight.
Internal BPA concentration in the host mice. In order to characterize this model, free
and total (free + glucuronide and sulfate conjugates) BPA concentration levels were assayed
in plasma of both exposed and control mice. Each sample (20 to 50 μL) was fortified with 10
ng of 13C-BPA (internal standard for quantification according to the isotope dilution
method), vortexed for 30 sec and followed by equilibration for 3h. For a total BPA determina-
tion, i.e.: free + phase II metabolites (glucuronide + sulfate), an enzymatic hydrolysis was car-
ried out using a purified Helix pomatia preparation (50˚C for 12h). Ethyl acetate (500 μL) was
added, the sample was shaken for around 30 sec and centrifuged at 5000 rpm for 15 min at
4˚C. The organic phase was collected into a 4 mL glass tube. This liquid/liquid extraction was
repeated twice. The resulting organic phase was evaporated to dryness under a gentle nitrogen
stream (45˚C). The dry residue was reconstituted in 100 μL acetonitrile and transferred to an
injection vial, and finally evaporated to dryness. Then, 20 μL of MSTFA [N-Methyl-N-(tri-
methylsilyl) trifluoroacetamide] were added to the dry residue and the vial was heated for 30
min at 45˚C. Detection was achieved using gas chromatography coupled to tandem mass
spectrometry (GC-MS/MS) operating in selected reaction monitoring (SRM) acquisition
mode as previously described [51,52]. The limit of detection of BPA in the plasma was
Fig 1. Xenografting first trimester human fetal testis. Human fetal testes (9.1–11.3 GW) xenografted in castrated
Nude (host) mice. Host mice received vehicle (Control) or 10μM BPA in the drinking water. (A) Host mouse six weeks
after xenografting demonstrating xenograft tissue below the skin (green circles). (B) Xenografted explants (green
circles) in the back muscle of the host mouse at the end of the experiment, in a control and a BPA-treated mouse. Scale
bar: 5 mm. (C) Histological section of a xenograft after haematoxylin-eosin-saffron staining, T: testis; M: mouse
muscle; C: connective tissue. Scale bar: 100 μm. (D) Histological section of a xenograft showing a blood vessel (BV) in
the interstitial tissue. LC: Leydig cell. Scale bar: 10 μm.
https://doi.org/10.1371/journal.pone.0191934.g001
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0.13 nM (0.03μg/L) and the limit of quantitation was 0.44 nM (0.1μg/L). All the samples were
above the limit of quantitation.
Plasma of BPA-treated mice contained 0.10 ± 0.04 μM total BPA, one third of which was
unconjugated (0.038 ± 0.010 μM) (Fig 2). Control mice exhibited detectable concentrations of
total and unconjugated BPA (0.02 ± 0.01 μM and 0.007 ± 0.001 μM respectively). In the litera-
ture, generally, internal level of BPA is not assayed in both control and treated animals. How-
ever, a recent study performed by the National Program of Toxicology carefully evaluated total
and unconjugated levels of BPA in the plasma of control rats and reported values in the same
order of magnitude as the present results [53]. Importantly, in the present study, both uncon-
jugated and total plasma BPA concentrations were significantly higher in the treated group
compared with controls.
Histological analyses. After dehydration the tissue pieces were embedded in paraffin wax
and sectioned at 5 μm thickness. Serial testes sections were deparaffinized, rehydrated and hae-
matoxylin-eosin-saffron staining or immunohistochemistry were performed as previously
described [54,55].
To evaluate the percentage of apoptotic and proliferative germ cells, immunohistochemistry
was performed using anti-cleaved caspase-3 (CC3; 1:100, Cell Signaling, 9661S) and anti-Ki67
(1:50, BD Pharmingen, cat 556609) antibodies respectively. Anti-AMH antibody (1:200, Santa
Cruz, sc6886) [48] was used to stain the Sertoli cells in order to aid identification of the AMH-
negative GC within the seminiferous cords. Immunohistochemistry was conducted using anti-
AP-2γ (1:100, Santa Cruz, sc12762) or anti-MAGE-A4 (1:1000, GeneTex, GTX116357) anti-
bodies to determine germ cell differentiation status. The primary antibodies were detected
using species-specific secondary antibodies conjugated with a peroxidase activity polymer
(ImmPRESS reagent kit; Vector Laboratories, Burlingame, CA). Peroxidase activity was visual-
ized in brown using DAB (3,3’-diaminobenzidine) as substrate or visualized in green using
Permanent HRP Green Kit (Zytomed Systems).
Fig 2. Effect of BPA exposure on plasma BPA concentration in xenografted mice. Plasma levels of BPA were
quantified by gas chromatography coupled to tandem mass spectrometry (GC-MS/MS) from castrated Nude male
mice xenografted with first trimester human fetal testis (9.1–11.3 GW, mean 10.2 ± 0.2 GW; n = 6–7) and exposed to
vehicle (Control) or BPA (10 μM in the drinking water) for five weeks. For each fetus, all the pieces from one testis
were grafted in a control mouse and all the pieces from the contralateral testis were grafted in a BPA-treated mouse.
Statistical analysis was performed using the Mann-Whitney test. p<0.05, p<0.01.
https://doi.org/10.1371/journal.pone.0191934.g002
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To quantify germ cell density, germ cells were identified based on morphological appear-
ance after haematoxylin-eosin-saffron staining and counted in several randomly chosen areas
each one measuring 0.464 mm2.
All counts were carried out blind using the Histolab analysis software (Microvision Instru-
ments, Evry, France). A minimum of 500 germ cells were counted per testis.
Testosterone radioimmunoassay. Serum testosterone concentration of Nude host mice
was measured as previously described [56]. The limit of detection was 80 pg/mL. The intra-
assay coefficient of variation (CoV) is 2% and the inter-assay CoV is 5%.
RNA extraction, reverse transcription and real-time Polymerase Chain Reaction. A
piece of each grafted testis was frozen in RLT buffer (Qiagen, Courtaboeuf, France) and stored
at– 20˚C. Total RNA from frozen samples was extracted using the RNeasy Mini-Kit (Qiagen,
Courtaboeuf, France) and reverse transcribed using the High Capacity cDNA Reverse, fol-
lowed by real-time PCR as previously described (48). The StepOne real-time PCR system
(ThermoFisher Scientific) and Quantifast Sybr green (Qiagen) were used for RT–qPCR. The
comparative ΔΔcycle threshold method was used to determine the relative quantities of spe-
cific key steroidogenic mRNA (STAR, CYP11A1,CYP17A1 and CYP19) using β-ACTIN, RPL0
and Cyclophilin A (CYPA) as reference genes. Each sample was run in duplicate. The sequences
of oligonucleotides used with SYBR-green detection were designed with Primer express Soft-
ware (Table 1).
Statistical analysis. All data are presented as means ± SEM. The statistical significance of
the difference between control and BPA-treated data were evaluated using the non-parametric
test: Wilcoxon for paired comparisons and Mann-Whitney for unpaired ones. Statistical sig-
nificance was set as p<0.05.
Second trimester human fetal testis xenograft studies
Collection of second trimester human fetal testis. Human testes (GW 14–18) were col-
lected from second-trimester fetuses (n = 4), obtained after the medical termination of preg-
nancy following written informed consent. Gestation was determined by ultrasound scan and
subsequent direct measurement of foot length. Ethical approval for obtaining the tissue was
given by the South East Scotland Research ethics committee (reference number LREC08/
S1101/1).
Host mice for xenografting. Male CD1 nude mice (aged 4–6 weeks; n = 64; Charles River
UK) were housed in individually ventilated cages with access to soy-free diet and water ad libi-
tum. In preparation for xenografting, mice were anesthetised by inhalation of isofluorane and
castrated through a scrotal incision. Castration was performed at least 2 weeks prior to xeno-
grafting. Following castration, mice received analgesia (Carprofen; Pfizer) in the drinking
water for 3 days post-surgery.
Table 1. Sequences of the primers.
Genes Forward sequence Reverse sequence
STAR CGTGGTACTCAGCATCGA TGGGCACAGTTGGGAACA
CYP11A1 TGGGTCGCCTATCACCAGTAT CCACCGGTCTTTCTTCCA
CYP17A1 CCACCTTTGCCCTGTTCAAG GCCAGCATATCACACAATGTACT
CYP19 TCACTGGCCTTTTTTCTCTTGGT GGGTCCAATTCCCATGCA
β-ACTIN TGACCCAGATCATGTTTGAGA TACGGCGAGAGGCGTACAGG
RPLP0 TCCCACTTGCTGAAAAGGTCA CAAAGGCAGATGGATCAGCC
CYPA CGCGTCTCCTTTGAGCTGTT ATTTTCTGCTGTCTTTGGGACC
https://doi.org/10.1371/journal.pone.0191934.t001
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Xenografting procedure. Human fetal testis xenografts were performed as previously
described [41]. Briefly, human fetal testes were cut into approximately 1 mm3 pieces and
grafted subcutaneously on either side of the midline of nude mice. Testis tissue pieces from
each human fetus testis were grafted into 1–3 host mice. Specific approval for the animal stud-
ies, including ethical approval was given by the UK Home office and all procedures were con-
ducted in accordance with the Animal (Scientific Procedures) Act 1986. Mice received corn oil
containing either vehicle (absolute ethanol) or BPA (Sigma-Aldrich) by daily gavage at a dose
of 0.5 or 50μg/kg of body weight for a period of 5 weeks. Mice were euthanized by inhalation
of CO2 and cervical dislocation. Blood was extracted by cardiac puncture for testosterone mea-
surements and seminal vesicles were removed and weighed.
Testosterone assay. Serum testosterone concentration of Nude host mice was measured
as described above for the first trimester. To perform relevant comparisons between values
observed in first and the second trimester xenografted mice hosts, all the plasma testosterone
extraction and assay were performed by the same investigator.
Statistical analysis
The method is the same as that used above for the studies of the first trimester testis.
Results
Effects of BPA exposure on first trimester human fetal testis
Effects of BPA on gonocyte apoptosis and proliferation in first trimester human fetal
testis using FeTA model. Human fetal testes from 6 to 12 GW, were cultured for 72 hours in
the presence or absence of BPA at various concentrations ranging from 0.01μM to 10 μM to
evaluate the effect of BPA on germ cells apoptosis (Fig 3A and 3B). Exposure to 10 μM BPA
significantly increased germ cells apoptosis ex vivo by 76 ± 37% (n = 8; p<0.05). However,
lower concentrations of BPA did not affect germ cells apoptosis.
Moreover, exposure to 10 μM BPA did not affect proliferation of human fetal germ cells
based on quantification of immunostaining for Ki-67 (Fig 3C and 3D).
Effect of BPA on germ cell apoptosis, proliferation and density in first trimester human
fetal testis xenografts. The percentage of apoptotic germ cells (CC3+) was increased by 35
±22% (n = 7) in the BPA-treated group compared with the controls, although this did not
reach statistically significance (Fig 4A and 4B). BPA exposure did not affect the percentage of
gonocyte proliferating (Ki67+) gonocytes (Fig 4C and 4D).
We hypothesized that a modest but sustained negative effect of BPA on germ cell apoptosis
during a longer period would impact on the germ cell density. Indeed, we observed that 5
weeks of treatment with BPA significantly reduced the density of germ cells by 19±7% (n = 9)
as compared with control (Fig 5).
Effect of BPA on germ cell differentiation in first trimester human fetal testis xeno-
grafts. Using immunohistochemistry, we quantified the percentage of germ cells expressing
a gonocyte marker (AP-2γ), and a pre-spermatogonial (MAGE-A4) marker (Fig 6A and 6C).
After BPA treatment, percentage of germ cells expressing AP-2γ was significantly decreased by
6.9 ± 2.7% (n = 9) whereas percentage of germ cells expressing MAGE-A4 was significantly
increased by 21.2 ± 6.2% (n = 8) compared with control (Fig 6B and 6D).
Effect of BPA on hCG-stimulated androgenic production in first trimester human fetal
testis xenografts. We analyzed endocrine function of control xenografts at the end of the
experiment. Seminal vesicle (SV) weight (an indirect measure of androgen production) of host
control mice was 230 ± 43 mg (Fig 7A) indicating secretion of testosterone during the six
weeks of xenografting. This is similar to SV weight (~280 mg) in non-castrated non-
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xenografted Nude mice whilst castrated non-xenografted Nude mice have SV weights of ~5–
10 mg. No significant differences were found in SV weight (Fig 7A) or plasma testosterone
level (Fig 7B) between BPA-treated and control mice. It should be noted that SV weight and
plasma testosterone concentration were significantly positively correlated both in controls
(r = 0.816, n = 6) and in BPA-treated mice (r = 0.845, n = 6).
To confirm the lack of effect of BPA on steroidogenesis, we measured the mRNA levels of
various key regulators in the steroidogenic pathway. BPA treatment did not affect the expres-
sion of STAR, CYP11A1,CYP17A1, and CYP19 regardless of the reference gene (Fig 7C).
Effects of BPA exposure on second trimester human fetal testis
Effect of BPA on hCG-stimulated androgenic production in second trimester human
fetal testis xenografts. Seminal vesicle weight and serum testosterone were measured in
host mice to determine testosterone production over the grafting period. No difference was
observed for seminal vesicle weight (Fig 8A) or serum testosterone (Fig 8B) after 5 weeks expo-
sure to 0.5 or 50 μg/kg/d BPA compared with vehicle-exposed control.
Discussion
The present study is the first experimental demonstration that exposure to environmentally
relevant BPA concentrations induces quantitative and qualitative effects in the development of
germ cells in the human fetal testis.
First, using the FeTA system, we demonstrated here that BPA has the potentiality to
increase germ cell apoptosis in first trimester human fetal testis ex vivo compared with control
conditions. However, this was only apparent at higher concentrations (10μM), whilst exposure
Fig 3. Effect of BPA exposure on germ cell apoptosis and proliferation in first trimester human fetal testes
cultured using the FeTA system. Human fetal testes (6–12 GW, mean 8.7 ± 0.6 GW) were cultured using the ex vivo
human Fetal Testis Assay system (hFeTA). After 24 hours in control medium, explants were cultured with 100 ng/mL
of LH for the 3 subsequent days in the presence of ethanol vehicle (control explants) or BPA at concentrations ranging
from 0.01 to 10 μM. Control and BPA-treated explants were paired samples from the same testis. (A) Histological
sections after labeling with anti-cleaved caspase-3 antibody (brown) and anti-AMH antibody (green). Positive (red
arrows) and negative (black arrows) germ cells can be identified. Scale bar: 10 μm. (B) Quantification of cleaved
caspase-3 positive cells (mean ± SEM; n = 4–8). (C) Histological sections after labeling with anti-Ki-67 antibody
(brown) and anti-AMH antibody (green). Positive (red arrows) and negative (black arrows) germ cells can be
identified. Scale bar: 50 μm. (D) Quantification of Ki67 positive gonocytes (mean ± SEM; n = 4–8).
https://doi.org/10.1371/journal.pone.0191934.g003
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to lower BPA concentrations (1, 0.1 and 0.01μM) had no effect. Using the FeTA system, we
were able to demonstrate a similar effect of BPA exposure on gonocyte apoptosis in the mouse
testis (S1 Fig). In this case, a concentration of 0.1 μM BPA was sufficient to significantly
increase apoptosis. This demonstrates, for the first time, BPA-induced apoptosis in the fetal
Fig 4. Effect of BPA exposure on germ cell apoptosis and proliferation in first trimester human fetal testis
xenografts. Human fetal testes (9.1–11.3 GW) were xenografted into castrate Nude (host) mice. Host mice received
vehicle (Control) or 10μM BPA in the drinking water for five weeks. (A) Histological sections of the testis after labeling
with anti-CC3 antibody (brown) and anti-AMH antibody (green). (B) Quantification of CC3+ cells displayed as
mean ± SEM (n = 7) on the left panel and as individual values with a line drawn between the control and the
corresponding BPA-treated testis from the same fetus on the right panel. (C) Histological sections after labeling with
anti-Ki-67 antibody (brown) and anti-AMH antibody (green). Positive (red arrows) and negative (black arrows) germ
cells can be identified. (D) Quantification of Ki67+ gonocytes displayed as mean ± SEM (n = 5) on the left panel and as
individual values with a line drawn between the control and the corresponding BPA-treated testis from the same fetus
on the right panel. Scale bars: 15 μm. Data analyzed using Wilcoxon paired test. For both apoptosis and proliferation,
the differences between vehicle and BPA-exposed groups were not statistically significant.
https://doi.org/10.1371/journal.pone.0191934.g004
Fig 5. Effect of BPA exposure on germ cell density in first trimester human fetal testis xenografts. Human fetal
testes (9.1–11.3 GW) were xenografted into castrate Nude (host) mice. Host mice received vehicle (Control) or 10μM
BPA in the drinking water for five weeks. (A) Histological sections after haematoxylin-eosin-saffron staining. Germ
cells (black arrow) can be easily identified. Scale bar: 20 μm. (B) Quantification of germ cell density displayed as
mean ± SEM (n = 9) on the left panel and as individual values with a line drawn between the control and the
corresponding BPA-treated testis from the same fetus on the right panel. Data analyzed using the Wilcoxon paired-
test. p<0.05 compared with control condition.
https://doi.org/10.1371/journal.pone.0191934.g005
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germ cells of rodents and human similar to that which has previously in adult rodents. Oral
administration of BPA in adult rodent (from 2 μg to 960 mg/ kg/day) induces germ cell apo-
ptosis [57–59] and increases oxidative stress in testis of adult rats at concentrations of 20 and
50 mg/kg/day [16,60]. In the same way a single injection of 50mg/kg BPA induced germ cell
apoptosis in the pubertal rat testis via an activation of p38 MAPK, a well-known marker of cel-
lular stress [61]. Furthermore, DNA damage has been demonstrated in cultured CHO-K1 and
Chicken DT40 cells exposed to BPA at concentrations ranging from 30 to 600 μM [62,63] and
in meiotic germ cells of C. elegans exposed to 1mM BPA and of mice exposed orally with
10mg/kg/day [64,65]. These cytotoxic effects of BPA may be responsible for the increase in
apoptosis and further investigation is required to determine whether such effects on oxidative
stress and DNA damages also occurs in male human fetal germ cells. Whilst these results show
consistent effects, the concentration of BPA to which the cells/tissues/animals were exposed is
often higher than those reported in the serum of humans. To focus on environmental BPA
concentrations, we utilized a xenograft model which allows longer term exposure using low
doses.
One important question when assessing one ED risk for human health is to appreciate
whether the chosen protocol reproduces BPA concentrations relevant to environmental expo-
sure in human. No data are available regarding the BPA level in the plasma of human fetuses
during intrauterine life. In the adult, although there remains some uncertainty and dispute,
about the level of effective exposure in humans [66,67], the overall consensus is that internal
Fig 6. Effect of BPA exposure on germ cell differentiation in first trimester human fetal testis xenografts. Human
fetal testes (9.1–11.3 GW) were xenografted into castrate Nude (host) mice. Host mice received vehicle (Control) or
10μM BPA in the drinking water for five weeks. (A) Histological sections of testes after immunostaining for AP-2γ
(gonocytes). Positive (red arrows) and negative (black arrows) germ cells can be identified. Scale bar: 60 μm. (B)
Quantification of AP-2γ-positive cells displayed as mean ± SEM (n = 9) on the left panel and as individual values with
a line drawn between the control and the corresponding BPA-treated testis from the same fetus on the right panel. (C)
Histological sections of testes after immunostaining for MAGE-A4 (prespermatogonia). Positive (red arrows) and
negative (black arrows) germ cells can be identified. Scale bar: 60 μm. (D) Quantification of MAGE-A4-positive cells
displayed as mean ± SEM (n = 8) on the left part and as individual values with a line drawn between the control and
the corresponding BPA-treated testis from the same fetus on the right part. Data analyzed using the Wilcoxon paired-
test. p<0.05, p<0.01.
https://doi.org/10.1371/journal.pone.0191934.g006
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exposure to unconjugated BPA, which is the only biologically active form of BPA [68], is in the
range of 0.002–0.043μM (i.e. 0.5–10μg/L) in blood and serum samples from healthy men and
non-pregnant women [69]. Internal BPA concentrations in pregnant women may be slightly
higher since different studies reported a mean value of 0.017 μM (3.88μg/L) [69], which this
was confirmed by a recent study [70]. Concentrations of unconjugated BPA in umbilical cord
blood of newborn are reported to range from 0.0006 to 0.021μM (i.e. 0.14 to 4.76μg/L) with a
mean value equal to 0.005 μM (1.12 μg/L) [71]. Lastly, it has been proposed that BPA might
accumulate particularly in younger fetuses because of lower metabolic clearance or conjuga-
tion at this developmental stage [72]. We took this into consideration when selecting our
dosing schedule. In the first series of experiments, it was an administration of BPA via the
drinking water and thus, the level of exposure had to be quantified in this model. We observed
that the plasma level of BPA, and hence the concentration to which the human testicular xeno-
grafts are exposed, was 0.1 and 0.038μM (i.e. 22,8 and 8.7μg/L) for total and unconjugated
BPA respectively. In the second series of experiments using host mice carrying second trimes-
ter human fetal testis xenografts, we administrated doses of 0.5 and 50μg/kg/day of BPA to the
treated host. By comparison, it is interesting to recall that 4 μg/kg/day, is the tolerable dose
intake (TDI) estimated by the EFSA. This TDI was derived from a Point of Departure which is
the equivalent to a Non Observable Adverse Level Effect (NOAEL) equal to 8,960μg/kg/day i.e.
higher than all the doses we used in the current series of experiments (0.5, 50, 500μg/kg/d).
Fig 7. Effect of BPA exposure on plasma testosterone level and seminal vesicle weight in the host mice
xenografted with first trimester human testes and on steroidogenic genes expression in the xenografts. Human
fetal testes (9.1–11.3 GW) were xenografted into castrate Nude (host) mice. Host mice received vehicle (Control) or
10 μM BPA in the drinking water for five weeks. (A) seminal vesicle weight displayed as mean ± SEM (n = 6) on the
left panel and as individual values with a line drawn between the control and the corresponding BPA-exposed testis
from the same fetus on the right panel. B) plasma testosterone concentration in host mice displayed as mean ± SEM
(n = 6) on the left panel and as individual values with a line drawn between the control and the corresponding BPA-
exposed testis from the same fetus on the right panel. C) Expression of key genes in the steroidogenic pathway (STAR,
CYP11A1, CYP17A1 and CYP19) using quantitative RT-PCR standardized to either β-ACTIN (ACTIN) or RPLP0 or
CYPA as endogenous control. Results are presented as a percentage of the control value (mean ± SEM; n = 4). Data
analyzed by Wilcoxon test. No significant difference between BPA-treated and control mice were identified.
https://doi.org/10.1371/journal.pone.0191934.g007
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Taken together, these data suggest that the three doses of BPA that we chose are relevant to
environmental exposure in human.
With the xenografting model, germ cell density in the grafts from the first trimester was sta-
tistically reduced after a 5-weeks exposure to BPA. This suggests that low doses of BPA pro-
voke a weak increase in germ cell apoptosis that is cumulative over the time, ultimately
resulting in a decrease in the germ cell number. Whether this degree of germ cell loss is subse-
quently compensated and the potential clinical significance is uncertain and would require fur-
ther investigation.
Importantly, we observed that BPA changed not only the germ cell number but also germ
cell differentiation status in first trimester testis xenografts. Exposure to BPA significantly
decreased the proportion of germ cells expressing AP-2γ a gonocyte marker and pluripotency
factor, whilst the proportion of germ cells expressing the pre-spermatogonial marker
MAGE-A4 was increased. It is known that the proportion of germ cells expressing AP-2γ
decreases during intrauterine life and finally disappears around 36 GW whilst the percentage
of germ cells expressing the pre-spermatogonial marker MAGE-A4 increases from the end of
the first trimester onwards [37–40,42]. Thus, our results suggest that BPA exposure could
accelerate progression of human germ cell differentiation from gonocyte to spermatogonia,
although the clinical importance of such a finding is unknown.
This study is the first to investigate the effect of BPA exposure on male germ cells differenti-
ation in human fetal testis; however, there are limited data on BPA effects on male fetal germ
cells differentiation in rodents. Using mouse ES cells, Aoki and Takada have shown that BPA
at 50 μM induces an up-regulation of Stra8, a meiotic entry gene, an increase in ovarian mark-
ers expression such as Wnt4 and Foxl2, and a decrease in testicular markers expression such as
Sox9 and Fgf9 [73]. Another study has described that treatment of pregnant mice with BPA at
40, 80 and 160μg BPA/kg body weight/day may induce epigenetic and gene expression
Fig 8. Effect of BPA exposure on testosterone plasma level and seminal vesicle weight in the host mice carrying
second trimester human fetal testis xenografts. Human fetal testes (14-18GW) xenografted into castrated Nude
(host) mice. Each human fetal testis was grafted into 1–3 host mice which received the same treatment. Host mice
received vehicle (Control), BPA (0.5μg/kg or 50μg/kg/d) daily by oral gavage for five weeks. A) seminal vesicle weight
as overall mean ± SEM (n = 4) is displayed on the left with individual values on the right. B) plasma testosterone
concentration in host mice as overall mean ± SEM (n = 4) is displayed on the left with individual values on the right.
Data analysed by Mann-Whitney test. No significant differences were observed for serum testosterone or seminal
vesicle weight between BPA-treated mice compared to control.
https://doi.org/10.1371/journal.pone.0191934.g008
Environmental doses of BPA disturb human fetal testis development
PLOS ONE | https://doi.org/10.1371/journal.pone.0191934 January 31, 2018 13 / 20
modifications in fetal germ cells in both sexes [74]. This may be related to the fact that BPA
alters the meiotic process in fetal oocytes in humans and non-human primates resulting in the
production of chromosomally abnormal eggs [75,76].
We also investigated the effect of BPA exposure on androgenic production in the first and
the second trimester human fetal testis. Androgen action during fetal life is important for the
process of masculinization of the male fetus. It has been shown in rats that a decrease in testos-
terone synthesis or action during a critical period (15.5 and 18.5 day post conception), named
“the masculinizing programming window” (MPW), causes masculinization defects that occur
from 18.5 dpc onwards, whilst a decrease in androgen production after this period does not
affect the ontogenesis of male reproductive organs but reduces their final size [77,78]. In
humans, the putative MPW extends from 8 to 14 GW [77,79] and masculinization begins on
GW 10 with subsequent growth throughout intrauterine life.
Importantly, we have demonstrated that five weeks exposure to low BPA concentrations
does not alter the hCG-stimulated testosterone secretion by xenografted human fetal testis.
This was observed for both first trimester and second trimester xenografts although there were
differences in the exposure route, the BPA doses and the grafting procedure between the two
series of experiments. Taken together, these results suggest that the effect of BPA on germ cells
described in the present study is unlikely to result from altered testosterone production despite
the importance of testosterone for gonocyte development [80,81]. The absence of a BPA effect
on hCG-stimulated testosterone production in the xenografting model is also in agreement
with previous results obtained using the FeTA system for which, we and others have shown
that concentrations of BPA lower than 10μM do not alter LH- or hCG-stimulated testosterone
production by human fetal testes [15,32]. However, using the same FeTA approach we have
also shown that 0.01μM and higher BPA concentrations reduce basal testosterone production
of the human fetal testes [31,32]. Given that hCG stimulation more accurately reflects the
physiological situation, we would consider the results obtained in the presence of LH or hCG
to be more representative of the situation in human pregnancy than those obtained under
basal conditions. However, hCG plasma concentrations change during development and can
vary considerably from one fetus to another [79] thus making precise replication of these in
vivo conditions challenging. Another challenge is that the endocrine milieu contains a mixture
of LH and hCG with a ratio changing from the end of the first trimester onwards.
Limited epidemiological studies have resulted in conflicting results in relation to associa-
tions between BPA exposure in utero and male reproductive abnormalities. A Chinese study
involving the sons of workers who were occupationally exposed to BPA during pregnancy
were shown to have a shorter anogenital distance (an index of fetal testicular testosterone pro-
duction) compared to a control group [82]. However, no increase in BPA concentration in
umbilical cord blood was observed in newborns with cryptorchidism [71], and no association
was found between concentrations of BPA and testosterone in umbilical cord blood in a popu-
lation-based cohort [83].
Conclusion
This is the first study performed by the same group comparing organ culture and xenograft
approaches for determining the effects of environmental chemical exposures in the human
fetal testis. Importantly, both ex vivo (FeTA) and in vivo (xenografts) resulted in similar effects
in terms of germ cell loss as a result of BPA exposure, whilst hCG-stimulated testosterone pro-
duction was unaffected in both systems. They appear as two complementary approaches since
FeTA can be used for high-throughput screening, dose-response and mechanism of action
studies, whereas xenografting can be used for long-term in vivo exposure studies.
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Although the fetal testis is well described as a potential target of EDs [15], we developed
here, using the xenograft model, the first experimental in vivo study of the effects of BPA on
the development and function of the human fetal testis using BPA exposures that have been
reported to reflect environmental exposure. With these conditions, BPA did not affect hCG-
stimulated androgenic function of the xenografted fetal testis but we did identify effects on
fetal germ cell number and differentiation that could potentially impact on fertility at
adulthood.
Supporting information
S1 Fig. Effect of BPA exposure on germ cell apoptosis in mouse fetal testes cultured using
the FeTA system. Testes were removed from NMRI mice at 12.5 day-post conception and cul-
tured as previously described using the FeTA system [29,31,48,49]. After 24 hours in control
medium, explants were cultured under basal conditions for the subsequent 24 hours in the
presence of ethanol (vehicle control) or 0.1 μM BPA. The effect of BPA on germ cell apoptosis
was estimated by the comparison between the percentage of cleaved caspase-3 positive gono-
cytes in the testis cultured in the presence of BPA and that measured in the other testis from
the same fetus cultured without BPA (control) as previously described [29,48]. Quantification
of cleaved caspase-3 positive cells are presented as mean ± SEM (n = 9) in the left panel and as
individual values with a line drawn between the control and the BPA-exposed testis from the
same fetus in the right panel. Data was analysed using the Wilcoxon paired test. The increase
in apoptosis in response to 0.1μM BPA was statistically significant (p = 0.027).
(TIF)
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